OBI-902
Solid Tumors (TROP2‑expressing)
Phase 1/2Active
Key Facts
About OBI Pharma
Taiwan‑based ADC specialist OBI Pharma advances glycan‑engineered antibody‑drug conjugates for oncology.
View full company profileSolid Tumors (TROP2‑expressing)
Taiwan‑based ADC specialist OBI Pharma advances glycan‑engineered antibody‑drug conjugates for oncology.
View full company profile